supply of inj. ixekizumab 80mg/ml in pfs per unit (item no. 2525 of si 2026-27) [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ] - inj. ixekizumab 80mg/ml in pfs per unit

North Central Railway has invited bids for the supply of inj. ixekizumab 80mg/ml in pfs per unit (item no. 2525 of si 2026-27) [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ] - inj. ixekizumab 80mg/ml in pfs per unit., with an EMD of ₹0 Cr. Please refer to the tender document for project value details. Interested bidders can submit applications until 8 October 2026, with the technical opening scheduled for 8 October 2026.